Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AstraZeneca
AstraZeneca
Sanofi expects RSV antibody to breach blockbuster status in 2024, even as supply hitch drags on
Fierce Pharma
Thu, 02/1/24 - 11:33 am
Sanofi
RSV
AstraZeneca
Beyfortus
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Daiichi Sankyo
AstraZeneca
Enhertu
earnings
As AstraZeneca gears up for courtroom showdown over IRA, Novo's case faces separate HHS rebuke
Fierce Pharma
Tue, 01/30/24 - 09:26 pm
AstraZeneca
Novo Nordisk
legal
Inflation Reduction Act
HHS
drug pricing
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
Incyte vets, with phase 1 within reach, raise $102M for new biotech to create better PARP, PI3K drugs
Fierce Biotech
Wed, 01/24/24 - 10:35 am
Synnovation Therapeutics
Incyte
AstraZeneca
GSK
Novartis
Pfizer
funding
cancer
PARP inhibitors
AstraZeneca reports positive data from Phase III trial of Imfinzi
Clinical Trials Arena
Mon, 01/22/24 - 11:29 am
AstraZeneca
Imfinzi
clinical trials
hepatocellular carcinoma
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
BioNTech
Duality Biologics
clinical trials
breast cancer
AstraZeneca
Daiichi Sankyo
HER2+ breast cancer
AZ bags first approval for PNH therapy danicopan, in Japan
Pharmaphorum
Fri, 01/19/24 - 09:38 am
AstraZeneca
Voydeya
PNH
danicopan
IRA lawsuits will be vital test of US’ ability to regulate pharma market
Clinical Trials Arena
Wed, 01/17/24 - 09:41 am
legal
Inflation Reduction Act
JNJ
AstraZeneca
HHS
drug pricing
Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference
Reuters
Fri, 01/5/24 - 11:25 am
M&A
JPMHC 2024
AbbVie
AstraZeneca
Bristol Myers Squibb
Carmot Therapeutics
Eli Lilly
AstraZeneca picks up a friend for Tagrisso in $40M upfront deal
Fierce Biotech
Tue, 01/2/24 - 10:05 pm
AstraZeneca
Allorion Therapeutics
lung cancer
Tagrisso
Biopharma Closes 2023 with Flurry of M&A Activity from AstraZeneca, BMS, Roche
BioSpace
Tue, 01/2/24 - 11:26 am
M&A
AstraZeneca
Gracell Biotechnologies
Bristol Myers Squibb
Rayze Bio
Roche
AZ, Sanofi’s Beyfortus cleared in China for RSV prevention
Pharmaphorum
Tue, 01/2/24 - 10:09 am
AstraZeneca
Sanofi
Beyfortus
RSV
vaccines
China
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
BioSpace
Wed, 12/27/23 - 11:08 pm
AstraZeneca
Gracell
cell therapy
M&A
FDA approves Ionis-AstraZeneca's nerve disease drug
Reuters
Fri, 12/22/23 - 09:42 am
Ionis Pharmaceuticals
AstraZeneca
FDA
Wainua
ATTR-PN
AstraZeneca, Sanofi to supply 230,000 more RSV infant shots to US market
Reuters
Thu, 12/14/23 - 10:48 pm
RSV
vaccines
Sanofi
AstraZeneca
AstraZeneca Buys into RSV Vaccine Market with Potential $1.1B Icosavax Purchase
BioSpace
Tue, 12/12/23 - 11:17 am
AstraZeneca
Icosavax
RSV
M&A
vaccines
ASH: With high tumor response, AstraZeneca spinout Dizal explores FDA path and US partner for PTCL drug
Fierce Biotech
Mon, 12/11/23 - 10:09 am
AstraZeneca
Dizal Pharmaceutical
blood cancer
peripheral T cell lymphoma
golidocitinib
clinical trials
ASH: As Novartis enters PNH market, AstraZeneca shows longer term effect of its latest contender
Fierce Biotech
Mon, 12/11/23 - 10:07 am
ASH 2023
AstraZeneca
Novartis
PNH
danicopan
AstraZeneca Just Joined the AI Drug Development Craze
Motley Fool
Sun, 12/10/23 - 11:08 pm
AstraZeneca
drug development
artificial intelligence
Absci
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »